Impairment of endothelium-dependent dilatation of the basilar artery during diabetes mellitus

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

The goal of this study was to determine whether responses of the basilar artery are altered during diabetes mellitus. We measured the diameter of the basilar artery in vivo in non-diabetic and diabetic rats (streptozotocin; 50-60 mg/kg i.p.). Responses of the basilar artery to agonists, which presumably produce dilatation by releasing endothelium-derived relaxing factor (EDRF), were impaired in diabetic rats compared to non-diabetic rats. Acetylcholine (1.0 and 10 μM) dilated the basilar artery by 13 ± 2 and 26 ± 4% (means ± S.E.M.), respectively, in non-diabetic rats, but by only 13 ± 1 and 9 ± 2%, respectively, in diabetic rats (P < 0.05). Bradykinin (1.0 and 10 μM) dilated the basilar artery by 14 ± 2 and 35 ± 6 % (means ± S.E.M.), respectively, in non-diabetic rats, but by only 5 ± 1 and 6± 2%, respectively, in diabetic rats (P < 0.05). The response to nitroglycerin was similar in non-diabetic and diabetic rats. Thus, impairment of vasodilatation in diabetic rats in response to acetylcholine and bradykinin is not related to non-specific impaired of vasodilation than impaired dilator responses of the basilar artery in response to acetylcholine and bradykinin in diabetic rats may be related to the activation of the thromboxane A2-prostaglandin H2 receptor. SQ 29548 (a specific thromboxane A2-prostaglandin H2 receptor antagonist) did not alter responses of the basilar artery to acetylcholine and bradykinin. These findings suggest that diabetes mellitus impairs endothelium-dependent dilation of the basilar artery. In addition, the mechanism of impaired responses of the basilar artery during diabetes mellitus does not appear to be related to the activation of the thromboxane A2-prostaglandin H2 receptor.

Original languageEnglish (US)
Pages (from-to)297-302
Number of pages6
JournalBrain Research
Volume580
Issue number1-2
DOIs
StatePublished - May 15 1992

Fingerprint

Basilar Artery
Endothelium
Dilatation
Diabetes Mellitus
Bradykinin
Prostaglandin H2 Receptors Thromboxane A2
Acetylcholine
Vasodilation
Endothelium-Dependent Relaxing Factors
Nitroglycerin
Streptozocin

Keywords

  • Acetylcholine
  • Bradykinin
  • Brain
  • Endothelium-derived relaxing factor
  • Nitroglycerin
  • Rat
  • SQ 29548
  • Stroke

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

Impairment of endothelium-dependent dilatation of the basilar artery during diabetes mellitus. / Mayhan, William.

In: Brain Research, Vol. 580, No. 1-2, 15.05.1992, p. 297-302.

Research output: Contribution to journalArticle

@article{e37dab6554c44f47a7b9bd61ce246475,
title = "Impairment of endothelium-dependent dilatation of the basilar artery during diabetes mellitus",
abstract = "The goal of this study was to determine whether responses of the basilar artery are altered during diabetes mellitus. We measured the diameter of the basilar artery in vivo in non-diabetic and diabetic rats (streptozotocin; 50-60 mg/kg i.p.). Responses of the basilar artery to agonists, which presumably produce dilatation by releasing endothelium-derived relaxing factor (EDRF), were impaired in diabetic rats compared to non-diabetic rats. Acetylcholine (1.0 and 10 μM) dilated the basilar artery by 13 ± 2 and 26 ± 4{\%} (means ± S.E.M.), respectively, in non-diabetic rats, but by only 13 ± 1 and 9 ± 2{\%}, respectively, in diabetic rats (P < 0.05). Bradykinin (1.0 and 10 μM) dilated the basilar artery by 14 ± 2 and 35 ± 6 {\%} (means ± S.E.M.), respectively, in non-diabetic rats, but by only 5 ± 1 and 6± 2{\%}, respectively, in diabetic rats (P < 0.05). The response to nitroglycerin was similar in non-diabetic and diabetic rats. Thus, impairment of vasodilatation in diabetic rats in response to acetylcholine and bradykinin is not related to non-specific impaired of vasodilation than impaired dilator responses of the basilar artery in response to acetylcholine and bradykinin in diabetic rats may be related to the activation of the thromboxane A2-prostaglandin H2 receptor. SQ 29548 (a specific thromboxane A2-prostaglandin H2 receptor antagonist) did not alter responses of the basilar artery to acetylcholine and bradykinin. These findings suggest that diabetes mellitus impairs endothelium-dependent dilation of the basilar artery. In addition, the mechanism of impaired responses of the basilar artery during diabetes mellitus does not appear to be related to the activation of the thromboxane A2-prostaglandin H2 receptor.",
keywords = "Acetylcholine, Bradykinin, Brain, Endothelium-derived relaxing factor, Nitroglycerin, Rat, SQ 29548, Stroke",
author = "William Mayhan",
year = "1992",
month = "5",
day = "15",
doi = "10.1016/0006-8993(92)90957-B",
language = "English (US)",
volume = "580",
pages = "297--302",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Impairment of endothelium-dependent dilatation of the basilar artery during diabetes mellitus

AU - Mayhan, William

PY - 1992/5/15

Y1 - 1992/5/15

N2 - The goal of this study was to determine whether responses of the basilar artery are altered during diabetes mellitus. We measured the diameter of the basilar artery in vivo in non-diabetic and diabetic rats (streptozotocin; 50-60 mg/kg i.p.). Responses of the basilar artery to agonists, which presumably produce dilatation by releasing endothelium-derived relaxing factor (EDRF), were impaired in diabetic rats compared to non-diabetic rats. Acetylcholine (1.0 and 10 μM) dilated the basilar artery by 13 ± 2 and 26 ± 4% (means ± S.E.M.), respectively, in non-diabetic rats, but by only 13 ± 1 and 9 ± 2%, respectively, in diabetic rats (P < 0.05). Bradykinin (1.0 and 10 μM) dilated the basilar artery by 14 ± 2 and 35 ± 6 % (means ± S.E.M.), respectively, in non-diabetic rats, but by only 5 ± 1 and 6± 2%, respectively, in diabetic rats (P < 0.05). The response to nitroglycerin was similar in non-diabetic and diabetic rats. Thus, impairment of vasodilatation in diabetic rats in response to acetylcholine and bradykinin is not related to non-specific impaired of vasodilation than impaired dilator responses of the basilar artery in response to acetylcholine and bradykinin in diabetic rats may be related to the activation of the thromboxane A2-prostaglandin H2 receptor. SQ 29548 (a specific thromboxane A2-prostaglandin H2 receptor antagonist) did not alter responses of the basilar artery to acetylcholine and bradykinin. These findings suggest that diabetes mellitus impairs endothelium-dependent dilation of the basilar artery. In addition, the mechanism of impaired responses of the basilar artery during diabetes mellitus does not appear to be related to the activation of the thromboxane A2-prostaglandin H2 receptor.

AB - The goal of this study was to determine whether responses of the basilar artery are altered during diabetes mellitus. We measured the diameter of the basilar artery in vivo in non-diabetic and diabetic rats (streptozotocin; 50-60 mg/kg i.p.). Responses of the basilar artery to agonists, which presumably produce dilatation by releasing endothelium-derived relaxing factor (EDRF), were impaired in diabetic rats compared to non-diabetic rats. Acetylcholine (1.0 and 10 μM) dilated the basilar artery by 13 ± 2 and 26 ± 4% (means ± S.E.M.), respectively, in non-diabetic rats, but by only 13 ± 1 and 9 ± 2%, respectively, in diabetic rats (P < 0.05). Bradykinin (1.0 and 10 μM) dilated the basilar artery by 14 ± 2 and 35 ± 6 % (means ± S.E.M.), respectively, in non-diabetic rats, but by only 5 ± 1 and 6± 2%, respectively, in diabetic rats (P < 0.05). The response to nitroglycerin was similar in non-diabetic and diabetic rats. Thus, impairment of vasodilatation in diabetic rats in response to acetylcholine and bradykinin is not related to non-specific impaired of vasodilation than impaired dilator responses of the basilar artery in response to acetylcholine and bradykinin in diabetic rats may be related to the activation of the thromboxane A2-prostaglandin H2 receptor. SQ 29548 (a specific thromboxane A2-prostaglandin H2 receptor antagonist) did not alter responses of the basilar artery to acetylcholine and bradykinin. These findings suggest that diabetes mellitus impairs endothelium-dependent dilation of the basilar artery. In addition, the mechanism of impaired responses of the basilar artery during diabetes mellitus does not appear to be related to the activation of the thromboxane A2-prostaglandin H2 receptor.

KW - Acetylcholine

KW - Bradykinin

KW - Brain

KW - Endothelium-derived relaxing factor

KW - Nitroglycerin

KW - Rat

KW - SQ 29548

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=0026771380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026771380&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(92)90957-B

DO - 10.1016/0006-8993(92)90957-B

M3 - Article

VL - 580

SP - 297

EP - 302

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -